Loading clinical trials...
Loading clinical trials...
The purpose of this study is to investigate patient related factors that contribute to increased risk of recurrent fractures and to investigate patient adherence to prescribed anti-osteoporotic drugs.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Oslo University Hospital
Collaborators
NCT06565910 · Femoral Neck Fractures, Femur Head Necrosis, and more
NCT07432737 · Hip Fractures
NCT06521671 · Femoral Neck Fractures, Internal Fixation; Complications, and more
NCT06455085 · Osteoporosis, Osteoporotic Fractures, and more
NCT06278987 · Hip Fractures
Baerum Hospital
Sandvika, Gjettum
St. Olavs Hospital
Trondheim, Trønderlag
Drammen hospital
Drammen
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions